Anticancer Active Heterocyclic Chalcones: Recent Developments

Author(s): Prasad Dandawate, Khursheed Ahmed, Subhash Padhye, Aamir Ahmad*, Bernhard Biersack*

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 21 , Issue 5 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Chalcones are structurally simple compounds that are easily accessible by synthetic methods. Heterocyclic chalcones have gained the interest of scientists due to their diverse biological activities. The anti-tumor activities of heterocyclic chalcones are especially remarkable and the growing number of publications dealing with this topic warrants an up-to-date compilation.

Methods: Search for antitumor active heterocyclic chalcones was carried out using Pubmed and Scifinder as common web-based literature searching tools. Pertinent and current literature was covered from 2015/2016 to 2019. Chemical structures, biological activities and modes of action of anti-tumor active heterocyclic chalcones are summarized.

Results: Simply prepared chalcones have emerged over the last years with promising antitumor activities. Among them, there are a considerable number of tubulin polymerization inhibitors. But there are also new chalcones targeting special enzymes such as histone deacetylases or with DNA-binding properties.

Conclusion: This review provides a summary of recent heterocyclic chalcone derivatives with distinct antitumor activities.

Keywords: Chalcone, heterocycle, anticancer agents, drug design, tubulin, histone deacetylase.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 21
ISSUE: 5
Year: 2021
Published on: 05 July, 2020
Page: [558 - 566]
Pages: 9
DOI: 10.2174/1871520620666200705215722
Price: $65

Article Metrics

PDF: 49